BC-CfE Updates

HIV Cure Research: An Update

Presenter:
Dr. Zabrina Brumme
Director, Laboratory

TasP® Update

Presenter:
Dr. Julio Montaner
Executive Director and Physician-in-Chief, BC Centre for Excellence in HIV/AIDS
Head, HIV/AIDS Program, St. Paul’s Hospital, Providence Health Care
UBC and St. Paul’s Foundation Chair in AIDS Research and UBC-Killam Professor, Faculty of Medicine, University of British Columbia

Research & Innovation at H2H

Presenter:
Dr. Pouya Azar

The Latest on COVID-19

Presenter:
Dr. Peter Phillips
Medical Director, Urban Health Acute Care Unit

Climate Change & Infectious Disease

Presenter:
Dr. Val Montessori
Director, Education & Training

Keynote Address

Presenter:
Dr. Nora Volkow
Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health

BC-CfE Hope to Health Overview

Presenter:
Dr. Rolando Barrios
Senior Medical Director, BC Centre for Excellence in HIV/AIDS
Director STOP HIV/AIDS® Program
Principal Investigator, Pharmacovigilance Initiative,
Interim Director, Epidemiology and Population Health & DTP
All Videos
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025

Start typing and press enter to search